145 related articles for article (PubMed ID: 22234795)
1. Urinary calcium excretion and insulin resistance in patients with acromegaly.
Libório AB; Figueiredo PR; Montenegro Junior RM; Montenegro RM; Martins MR; Silva Junior GB; Porto IA; Mota JI; Daher E
Int Urol Nephrol; 2012 Oct; 44(5):1473-7. PubMed ID: 22234795
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?
Kamenický P; Blanchard A; Gauci C; Salenave S; Letierce A; Lombès M; Brailly-Tabard S; Azizi M; Prié D; Souberbielle JC; Chanson P
J Clin Endocrinol Metab; 2012 Jun; 97(6):2124-33. PubMed ID: 22496496
[TBL] [Abstract][Full Text] [Related]
3. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency.
Hoogenberg K; Sluiter WJ; Dullaart RP
Acta Endocrinol (Copenh); 1993 Aug; 129(2):151-7. PubMed ID: 8372600
[TBL] [Abstract][Full Text] [Related]
5. [The frequency and mechanisms of urolithiasis in acromegaly].
Ieki Y; Miyakoshi H; Nagai Y; Bando Y; Usuda R; Miyamoto I; Ohsawa K; Kobayashi K
Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):755-63. PubMed ID: 1889513
[TBL] [Abstract][Full Text] [Related]
6. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
8. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
[TBL] [Abstract][Full Text] [Related]
9. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
10. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.
Niculescu D; Purice M; Coculescu M
Pituitary; 2013 Jun; 16(2):168-74. PubMed ID: 22562529
[TBL] [Abstract][Full Text] [Related]
12. Association of Urinary Sodium Excretion With Insulin Resistance in Korean Adolescents: Results From the Korea National Health and Nutrition Examination Survey 2009-2010.
Chun YH; Han K; Kim DH; Park YG; Cho KH; Choi YS; Kim SM; Kim YH; Nam GE
Medicine (Baltimore); 2016 Apr; 95(17):e3447. PubMed ID: 27124037
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
14. Biochemical assessment of bone formation and resorption in acromegaly.
Ezzat S; Melmed S; Endres D; Eyre DR; Singer FR
J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
[TBL] [Abstract][Full Text] [Related]
15. Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma.
Schmiedl A; Schwille PO
Magnes Res; 2003 Sep; 16(3):192-205. PubMed ID: 14596324
[TBL] [Abstract][Full Text] [Related]
16. The possible role of mRNA expression changes of GH/IGF-1/insulin axis components in subcutaneous adipose tissue in metabolic disturbances of patients with acromegaly.
Touskova V; Klouckova J; Durovcova V; Lacinova Z; Kavalkova P; Trachta P; Kosak M; Mraz M; Haluzikova D; Hana V; Marek J; Krsek M; Haluzik M
Physiol Res; 2016 Jul; 65(3):493-503. PubMed ID: 27070751
[TBL] [Abstract][Full Text] [Related]
17. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
18. Urinary phosphate excretion in the pathophysiology of idiopathic recurrent calcium urolithiasis: hormonal interactions and lipid metabolism.
Schwille PO; Herrmann U; Schmiedl A; Kissler H; Wipplinger J; Manoharan M
Urol Res; 1997; 25(6):417-26. PubMed ID: 9443652
[TBL] [Abstract][Full Text] [Related]
19. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
20. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.
Takamoto S; Tsuchiya H; Onishi T; Morimoto S; Imanaka S; Mori S; Seino Y; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):7-11. PubMed ID: 3839000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
